Clinical experience with hedgehog pathway inhibitors

Journal of Clinical Oncology

Volumn 28, Issue 36, 2010, Pages 5321-5326

  Low, Jennifer A ^a   De Sauvage, Frederic J ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO N [4 CHLORO 3 (2 PYRIDINYL)PHENYL] 4 METHANESULFONYLBENZAMIDE; ANTINEOPLASTIC AGENT; BEVACIZUMAB; BMS 833923; BORTEZOMIB; CAPECITABINE; CARBOPLATIN; CISPLATIN; DASATINIB; DEXAMETHASONE; ERLOTINIB; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IPI 926; IRINOTECAN; LDE 225; LENALIDOMIDE; OXALIPLATIN; PF 04449913; PROTEIN INHIBITOR; RO 4929097; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG; XL 139;

BASAL CELL CARCINOMA; BREAST CARCINOMA; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CHRONIC MYELOID LEUKEMIA; COLORECTAL CANCER; EMBRYO DEVELOPMENT; GENE MUTATION; GENE OVEREXPRESSION; GLIOBLASTOMA; HEMATOPOIESIS; HUMAN; LUNG SMALL CELL CANCER; MEDULLOBLASTOMA; MYELOMA; NONHUMAN; OVARY CANCER; OVARY CARCINOMA; PANCREAS CANCER; PANCREAS CARCINOMA; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR; STOMACH CARCINOMA; STROMA;

ADULT; ANILIDES; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; CEREBELLAR NEOPLASMS; CHILD; HEDGEHOG PROTEINS; HUMANS; MEDULLOBLASTOMA; PARACRINE COMMUNICATION; PYRIDINES; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; SKIN NEOPLASMS;

EID: 79951904426     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.27.9943     Document Type: Review

References (69)

1. Varjosalo M, Taipale J: Hedgehog: Functions and mechanisms. Genes Dev 22:2454-2472, 2008
2. Ingham PW, McMahon AP: Hedgehog signaling in animal development: Paradigms and principles. Genes Dev 15:3059-3087, 2001 (Pubitemid 33115673)
3. Wang Y, Zhou Z, Walsh CT, et al: Selective translocation of intracellular smoothened to the primary cilium in response to hedgehog pathway modulation. Proc Natl Acad Sci U S A 106:2623-2628, 2009
4. Milenkovic L, Scott MP, Rohatgi R: Lateral transport of Smoothened from the plasma membrane to the membrane of the cilium. J Cell Biol 187:365-374, 2009
5. Eggenschwiler JT, Anderson KV: Cilia and developmental signaling. Annu Rev Cell Dev Biol 23:345-373, 2007
6. Huangfu D, Anderson KV: Cilia and Hedgehog responsiveness in the mouse. Proc Natl Acad Sci U S A 102:11325-11330, 2005 (Pubitemid 41153819)
7. Rohatgi R, Scott MP: Patching the gaps in hedgehog signaling. Nat Cell Biol 9:1005-1009, 2007
8. Jiang J: Regulation of Hh/Gli signaling by dual ubiquitin pathways. Cell Cycle 5:2457-2463, 2006
9. Ingham PW, McMahon AP: Hedgehog signaling: Kif7 is not that fishy after all. Curr Biol 19:R729-31, 2009
10. Wong SY, Reiter JF: The primary cilium at the crossroads of mammalian hedgehog signaling. Curr Top Dev Biol 85:225-260, 2008
11. Duman-Scheel M, Weng L, Xin S, et al: Hedgehog regulates cell growth and proliferation by inducing cyclin D and cyclin E. Nature 417:299-304, 2002 (Pubitemid 34534713)
12. Bigelow RL, Chari NS, Unden AB, et al: Transcriptional regulation of bcl-2 mediated by the sonic hedgehog signaling pathway through gli-1. J Biol Chem 279:1197-1205, 2004 (Pubitemid 38082643)
13. Pola R, Ling LE, Silver M, et al: The morphogen sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors. Nat Med 7:706-711, 2001 (Pubitemid 32588027)
14. Louro ID, Bailey EC, Li X, et al: Comparative gene expression profile analysis of GLI and c-MYC in an epithelial model of malignant transformation. Cancer Res 62:5867-5873, 2002 (Pubitemid 35204747)
15. Feldmann G, Dhara S, Fendrich V, et al: Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: A new paradigm for combination therapy in solid cancers. Cancer Res 67:2187-2196, 2007 (Pubitemid 46424238)
16. McMahon AP, Ingham PW, Tabin CJ: Developmental roles and clinical significance of hedgehog signaling. Curr Top Dev Biol 53:1-114, 2003 (Pubitemid 137639458)
17. Beachy PA, Karhadkar SS, Berman DM: Tissue repair and stem cell renewal in carcinogenesis. Nature 432:324-331, 2004 (Pubitemid 39551660)
18. Bryden MM, Evans HE, Keeler RF: Cyclopia in sheep caused by plant teratogens. J Anat 110:507, 1971
19. Chen JK, Taipale J, Cooper MK, et al: Inhibition of hedgehog signaling by direct binding of cyclopamine to smoothened. Genes Dev 16:2743-2748, 2002 (Pubitemid 35253140)
20. Frank-Kamenetsky M, Zhang XM, Bottega S, et al: Small-molecule modulators of hedgehog signaling: Identification and characterization of smoothened agonists and antagonists. J Biol 1:10, 2002
21. Chen JK, Taipale J, Young KE, et al: Small molecule modulation of smoothened activity. Proc Natl Acad Sci U S A 99:14071-14076, 2002 (Pubitemid 35257626)
22. Williams JA, Guicherit OM, Zaharian BI, et al: Identification of a small molecule inhibitor of the hedgehog signaling pathway: Effects on basal cell carcinoma-like lesions. Proc Natl Acad Sci U S A 100:4616-4621, 2003 (Pubitemid 36457779)
23. Tremblay MR, Nesler M, Weatherhead R, et al: Recent patents for Hedgehog pathway inhibitors for the treatment of malignancy. Expert Opin Ther Pat 19:1039-1056, 2009
24. Mahindroo N, Punchihewa C, Fujii N: Hedgehog-Gli signaling pathway inhibitors as anticancer agents. J Med Chem 52:3829-3845, 2009
25. Robarge KD, Brunton SA, Castanedo GM, et al: GDC-0449: A potent inhibitor of the hedgehog pathway. Bioorg Med Chem Lett 19:5576-5581, 2009
26. Olive KP, Jacobetz MA, Davidson CJ, et al: Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324:1457-1461, 2009
27. Tremblay MR, Nevalainen M, Nair SJ, et al: Semisynthetic cyclopamine analogues as potent and orally bioavailable hedgehog pathway antagonists. J Med Chem 51:6646-6649, 2008
28. Yauch RL, Gould SE, Scales SJ, et al: A paracrine requirement for hedgehog signaling in cancer. Nature 455:406-410, 2008
29. Tian H, Callahan CA, DuPree KJ, et al: Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis. Proc Natl Acad Sci U S A 106:4254-4259, 2009
30. Bailey JM, Swanson BJ, Hamada T, et al: Sonic hedgehog promotes desmoplasia in pancreatic cancer. Clin Cancer Res 14:5995-6004, 2008
31. Fan L, Pepicelli CV, Dibble CC, et al: Hedgehog signaling promotes prostate xenograft tumor growth. Endocrinology 145:3961-3970, 2004 (Pubitemid 39037585)
32. Thayer SP, di Magliano MP, Heiser PW, et al: Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425:851-856, 2003 (Pubitemid 37355945)
33. Nolan-Stevaux O, Lau J, Truitt ML, et al: GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation. Genes Dev 23:24-36, 2009
34. Byrd N, Grabel L: Hedgehog signaling in murine vasculogenesis and angiogenesis. Trends Cardiovasc Med 14:308-313, 2004 (Pubitemid 41110609)
35. Dierks C, Grbic J, Zirlik K, et al: Essential role of stromally induced hedgehog signaling in B-cell malignancies. Nat Med 13:944-951, 2007 (Pubitemid 47222041)
36. Hegde GV, Peterson KJ, Emanuel K, et al: Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: A potential new therapeutic target. Mol Cancer Res 6:1928-1936, 2008
37. Visvader JE, Lindeman GJ: Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions. Nat Rev Cancer 8:755-768, 2008
38. Bar EE, Chaudhry A, Lin A, et al: Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells 25:2524-2533, 2007 (Pubitemid 47582744)
39. Li C, Heidt DG, Dalerba P, et al: Identification of pancreatic cancer stem cells. Cancer Res 67:1030-1037, 2007
40. Liu S, Dontu G, Mantle ID, et al: Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66:6063-6071, 2006
41. Peacock CD, Wang Q, Gesell GS, et al: Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc Natl Acad Sci U S A 104:4048-4053, 2007 (Pubitemid 47181576)
42. Zhao C, Chen A, Jamieson CH, et al: Hedgehog signaling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 458:776-779, 2009
43. Dierks C, Beigi R, Guo GR, et al: Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell 14:238-249, 2008
44. Goodrich LV, Milenkovic L, Higgins KM, et al: Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 277:1109-1113, 1997 (Pubitemid 27371635)
45. Hahn H, Wicking C, Zaphiropoulous PG, et al: Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85:841-851, 1996 (Pubitemid 26192135)
46. Epstein EH: Basal cell carcinomas: Attack of the hedgehog. Nat Rev Cancer 8:743-754, 2008
47. Dahmane N, Lee J, Robins P, et al: Activation of the transcription factor Gli1 and the sonic hedgehog signaling pathway in skin tumours. Nature 389: 876-881, 1997 (Pubitemid 27462984)
48. Unden AB, Zaphiropoulos PG, Bruce K, et al: Human patched (PTCH) mRNA is overexpressed consistently in tumor cells of both familial and sporadic basal cell carcinoma. Cancer Res 57:2336-2340, 1997 (Pubitemid 27255884)
49. Gailani MR, Stahle-Backdahl M, Leffell DJ, et al: The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat Genet 14:78-81, 1996 (Pubitemid 26301550)
50. Reifenberger J, Wolter M, Weber RG, et al: Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 58:1798-1803, 1998 (Pubitemid 28217449)
51. Thompson MC, Fuller C, Hogg TL, et al: Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol 24:1924-1931, 2006
52. Corcoran RB, Scott MP: A mouse model for medulloblastoma and basal cell nevus syndrome. J Neurooncol 53:307-318, 2001 (Pubitemid 33034682)
53. Svard J, Heby-Henricson K, Persson-Lek M, et al: Genetic elimination of suppressor of fused reveals an essential repressor function in the mammalian hedgehog signaling pathway. Dev Cell 10:187-197, 2006 (Pubitemid 43174952)
54. Fan H, Oro AE, Scott MP, et al: Induction of basal cell carcinoma features in transgenic human skin expressing sonic hedgehog. Nat Med 3:788-792, 1997
55. Nilsson M, Unden AB, Krause D, et al: Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1. Proc Natl Acad Sci U S A 97:3438-3443, 2000 (Pubitemid 30183321)
56. Sheng H, Goich S, Wang A, et al: Dissecting the oncogenic potential of Gli2: Deletion of an NH(2)-terminal fragment alters skin tumor phenotype. Cancer Res 62:5308-5316, 2002 (Pubitemid 35024607)
57. Xie J, Murone M, Luoh SM, et al: Activating smoothened mutations in sporadic basal-cell carcinoma. Nature 391:90-92, 1998 (Pubitemid 28079221)
58. Romer JT, Kimura H, Magdaleno S, et al: Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice. Cancer Cell 6:229-240, 2004 (Pubitemid 39222036)
59. Sasai K, Romer JT, Lee Y, et al: Shh pathway activity is down-regulated in cultured medulloblastoma cells: Implications for preclinical studies. Cancer Res 66:4215-4222, 2006
60. Lee Y, Kawagoe R, Sasai K, et al: Loss of suppressor-of-fused function promotes tumorigenesis. Oncogene 26:6442-6447, 2007 (Pubitemid 47494220)
61. American Cancer Society: Cancer Facts and Figures 2009. http://www.cancer.org/acs/groups/content/@nho/documents/document/500809webpdf. pdf
62. Rubin AI, Chen EH, Ratner D: Basal-cell carcinoma. N Engl J Med 353:2262-2269, 2005 (Pubitemid 41697289)
63. Von Hoff DD, LoRusso PM, Rudin CM, et al: Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 361:1164-1172, 2009
64. Siu L, Papadopoulos KP, Alberts S: A first-inhuman phase 1 study of an oral hedgehog pathway antagonist, BMS-833923 (XL139), in subjects with advanced or metastatic solid tumors. AACR-NCIEORTC Molecular Targets and Cancer Therapeutics, Boston, MA, November 15-19, 2009 (abstr 55)
65. Packer RJ, Cogen P, Vezina G, et al: Medulloblastoma: Clinical and biologic aspects. Neuro Oncol 1:232-250, 1999
66. Packer RJ, Sutton LN, Atkins TE, et al: A prospective study of cognitive function in children receiving whole-brain radiotherapy and chemotherapy: 2-year results. J Neurosurg 70:707-713, 1989 (Pubitemid 19124181)
67. Kimura H, Ng JM, Curran T: Transient inhibition of the hedgehog pathway in young mice causes permanent defects in bone structure. Cancer Cell 13:249-260, 2008 (Pubitemid 351324879)
68. Rudin CM, Hann CL, Laterra J, et al: Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med 361:1173-1178, 2009
69. Yauch RL, Dijkgraaf GJ, Alicke B, et al: Smoothened mutation confers resistance to a hedgehog pathway inhibitor in medulloblastoma. Science 326:572-574, 2009